Imaging Young Myeloma (IMAgerie JEune Myélome)

Pharmacoeconomic and Clinical Prospective Comparison of PET-scan and MRI in Patients With de Novo Multiple Myeloma Less Than 65 Years of Age Treated According to IFM/DFCI 2009 Clinical Trial.

Multicenter open-label prospective comparative study of PET-scan and MRI at the time of diagnosis, after 3 cycles of induction therapy (RVD) and at the completion of therapy.

Inclusion Criteria:

• symptomatic de novo multiple myeloma
• less than 65 years of age
• enrolled in the IFM/DFCI clinical trial

Exclusion Criteria:

• 66 years of age or more
• not eligible for high-dose therapy
• Cons-indications to MRI or PET-Scan